Plus, news about SpliSense, Radiance, Novatim Immune Therapeutics, Precigen, Emergent BioSolutions, LPOXY, Novartis, Valneva and Rallybio:
🫀 Mineralys Therapeutics’ $250M stock sale: The company disclosed the offering after AstraZeneca
↧